Nutanix Inc Q4 2022 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Pinjalim Bora - JPMorgan Chase & Co, Research Division - Analyst : Congrats on a great quarter, much better than expected here. I want to ask you about, again, the ACV billings guidance. It seems like you took some conservatism into that for the new business, but seems like you might not have factored much into the renewals business. I'm just trying to understand what exactly are you assuming? Are you assuming close rates to deteriorate? Are you assuming elongation of sales cycles, maybe any context there would be helpful.

Question: Pinjalim Bora - JPMorgan Chase & Co, Research Division - Analyst : Understood. One question for Rajiv. You introduced the pricing and packaging earlier in the year. You have noted some kind of full end-to-end customers adopting Nutanix. Are you starting with -- especially with the acquisition of one of your largest customers as a backdrop, I guess, are you seeing any meaningful change in customer conversations, learning more strategic to adopting Nutanix in a broader sense?

Question: Daniel Robert Bergstrom - RBC Capital Markets, Research Division - Analyst : It's Dan Bergstrom for Matt Hedberg. On the supply chain challenges, sounded like it tracked better than expected. That's great to hear that. Last quarter, you noted they started very late in the quarter. Just wondering about the timing of improvement this quarter. Was it -- was the supply chain consistently better than you thought? Or was there more of a gradual improvement through the quarter?

Question: Daniel Robert Bergstrom - RBC Capital Markets, Research Division - Analyst : Great. Thanks for the clarification.